Holen Sie sich die Stockscreener-App
10.53
5.30%
0.53
Handel nachbörslich:
10.90
0.37
+3.51%
Schlusskurs vom Vortag:
$10.00
Offen:
$10.19
24-Stunden-Volumen:
510.91K
Relative Volume:
1.34
Marktkapitalisierung:
$294.73M
Einnahmen:
$30.43M
Nettoeinkommen (Verlust:
$-18.15M
KGV:
-15.26
EPS:
-0.69
Netto-Cashflow:
$-9.08M
1W Leistung:
-4.01%
1M Leistung:
-10.00%
6M Leistung:
-42.68%
1J Leistung:
+51.29%
1-Tages-Spanne:
$10.14
$10.62
1-Wochen-Bereich:
$9.94
$11.07
52-Wochen-Spanne:
$6.25
$19.22
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Firmenname
Clearpoint Neuro Inc
Sektor
Branche
Telefon
(949) 900-6833
Adresse
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Vergleichen Sie CLPT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
10.53 | 282.65M | 30.43M | -18.15M | -9.08M | -0.69 |
|
ABT
Abbott Laboratories
|
129.93 | 221.54B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.79 | 156.19B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
381.49 | 144.43B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
89.64 | 114.47B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
80.09 | 46.53B | 5.69B | 4.15B | 623.10M | 6.95 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-25 | Fortgesetzt | B. Riley Securities | Buy |
| 2023-10-24 | Eingeleitet | Stifel | Buy |
| 2023-02-16 | Fortgesetzt | B. Riley Securities | Buy |
| 2022-04-05 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-03-18 | Eingeleitet | Lake Street | Buy |
| 2020-07-17 | Eingeleitet | B. Riley FBR | Buy |
Alle ansehen
Clearpoint Neuro Inc Aktie (CLPT) Neueste Nachrichten
ClearPoint Neuro Announces Progression of Key Partner Milestones throughout the Global Biologics and Drug Delivery Portfolio - ACCESS Newswire
Breakthrough: US Hospitals Complete First-Ever Commercial Gene Therapy Brain Treatments for Rare Disease - Stock Titan
How does ClearPoint Neuro Inc. generate profit in a changing economyHigh-profit capital plays - Jammu Links News
What catalysts could drive ClearPoint Neuro Inc. stock higher in 2025Achieve unparalleled market performance - Jammu Links News
What are analysts’ price targets for ClearPoint Neuro Inc. in the next 12 monthsFree Trend-Following Techniques - Jammu Links News
What are the technical indicators suggesting about ClearPoint Neuro Inc.Accelerated earnings growth - Jammu Links News
Should I hold or sell ClearPoint Neuro Inc. stock in 2025Invest confidently with professional market insights - Jammu Links News
Is ClearPoint Neuro Inc. stock overvalued or undervaluedExplosive wealth accumulation - Jammu Links News
How many analysts rate ClearPoint Neuro Inc. as a “Buy”Exceptional stock performance - Jammu Links News
How strong is ClearPoint Neuro Inc. company’s balance sheetBuild wealth faster with consistent growth stocks - Jammu Links News
ClearPoint Neuro Inc. Tests 50 Day MA After Sharp DeclineGrowth Based Stock Signal Screener Updated - beatles.ru
Is ClearPoint Neuro Inc. a good long term investmentFree Trend-Following Techniques - Jammu Links News
When is ClearPoint Neuro Inc. stock expected to show significant growthInvest smarter with daily market updates - Jammu Links News
What analysts say about ClearPoint Neuro Inc. stockAchieve breakthrough investment performance - Jammu Links News
Is ClearPoint Neuro Inc. a growth stock or a value stockUnlock powerful portfolio optimization tools - Jammu Links News
What drives ClearPoint Neuro Inc. stock priceAchieve superior returns with professional insights - Jammu Links News
What are ClearPoint Neuro Inc. company’s key revenue driversBuild wealth with steady, reliable stocks - jammulinksnews.com
How does ClearPoint Neuro Inc. compare to its industry peersInvest confidently with real-time data - jammulinksnews.com
Analyzing net buyer seller activity in ClearPoint Neuro Inc.Free Reliable Chart-Based Trade Entries - Newser
Relative strength of ClearPoint Neuro Inc. in sector analysisIn-Depth Stock Trading Volume Analysis - Newser
What institutional investors are buying ClearPoint Neuro Inc. stockBreakout Stocks Picks For Every Investor - Jammu Links News
Leading vs lagging indicators on ClearPoint Neuro Inc. performanceMarket Timing Strategy with Technical Filters - Newser
Developing predictive dashboards with ClearPoint Neuro Inc. dataValue Investing Summary and Earnings Outlook - Newser
Will ClearPoint Neuro Inc. stock benefit from AI tech trendsConservative Equity Setup with Signal Analysis - Newser
ClearPoint Neuro's 15min chart displays Bollinger Bands Narrowing, Bearish Marubozu. - AInvest
Why ClearPoint Neuro Inc. stock attracts strong analyst attentionChart Pattern Strategy with ROI Focus - Newser
ClearPoint Neuro Inc. stock outlook for YEARFree Entry and Exit Strategy Optimizer Tool - Newser
How high can ClearPoint Neuro Inc. stock price go in 2025Technical Chart Summary for Momentum Stocks - Newser
ClearPoint Neuro Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingShort Squeeze Opportunities with Indicators - Newser
What makes ClearPoint Neuro Inc. stock price move sharplyFree Conservative Entry for High Return Setup - Newser
Can momentum traders help lift ClearPoint Neuro Inc.AI-Based Stock Behavior Forecast Engine - Newser
Will Volume Confirm Reversal in ClearPoint Neuro Inc.Low Volatility Stable Growth Picks Rank High - metal.it
What risks could impact ClearPoint Neuro Inc. stock performanceCapital Protection Trading Strategies Gain Interest - metal.it
Is it the right time to buy ClearPoint Neuro Inc. stockAchieve rapid financial growth with expert help - jammulinksnews.com
Does ClearPoint Neuro Inc. stock perform well during market downturnsFree Stock Chart Pattern Guide - Jammu Links News
What is the dividend policy of ClearPoint Neuro Inc. stockConsistent triple-digit returns - Jammu Links News
Finanzdaten der Clearpoint Neuro Inc-Aktie (CLPT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.00%
3.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):